Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › KY › FORT THOMAS › ST ELIZABETH MEDICAL CENTER, INC

ST ELIZABETH MEDICAL CENTER, INC

NPI: 1740221795 · FORT THOMAS, KY 41075 · Substance Use Disorder Rehabilitation Clinic/Center · NPI assigned 06/09/2006

$45.99M
Total Medicaid Paid
696,134
Total Claims
494,170
Beneficiaries
268
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialRITCHEY-BALDWIN, LORI (CFO (INTERIM))
NPI Enumeration Date06/09/2006

Related Entities

Other providers sharing the same authorized official: RITCHEY-BALDWIN, LORI

ProviderCityStateTotal Paid
ST ELIZABETH MEDICAL CENTER, INC EDGEWOOD KY $188.25M
ST ELIZABETH MEDICAL CENTER, INC FLORENCE KY $65.44M
ST ELIZABETH MEDICAL CENTER, INC WILLIAMSTOWN KY $35.42M
ST ELIZABETH MEDICAL CENTER, INC LAWRENCEBURG IN $4.66M
ST ELIZABETH MEDICAL CENTER, INC ERLANGER KY $3.75M
ST ELIZABETH MEDICAL CENTER, INC EDGEWOOD KY $2.95M
ST. ELIZABETH MEDICAL CENTER, INC. EDGEWOOD KY $438.18

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 117,869 $6.11M
2019 110,102 $6.42M
2020 77,818 $4.89M
2021 88,206 $5.46M
2022 94,872 $6.34M
2023 117,897 $9.92M
2024 89,370 $6.85M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 31,851 27,965 $7.47M
41899 Unlisted procedure, dentoalveolar structures 2,504 2,318 $7.11M
99284 Emergency department visit for the evaluation and management, high severity 19,658 15,931 $6.85M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 11,534 7,111 $4.48M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 18,169 11,701 $1.63M
G0378 Hospital observation service, per hour 7,725 2,984 $1.47M
74177 Computed tomography, abdomen and pelvis; with contrast material 6,889 6,177 $1.45M
99282 Emergency department visit for the evaluation and management, low to moderate severity 8,028 7,489 $1.21M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 5,301 2,211 $1.20M
J3490 Unclassified drugs 53,469 11,615 $985K
96361 Intravenous infusion, hydration; each additional hour 15,164 8,051 $670K
64493 415 281 $453K
71046 Radiologic examination, chest; 2 views 10,247 8,766 $445K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 6,216 3,229 $442K
70450 Computed tomography, head or brain; without contrast material 5,209 4,228 $403K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,250 1,149 $346K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 14,722 12,954 $316K
96375 Therapeutic injection; each additional sequential IV push 8,903 7,020 $311K
36415 Collection of venous blood by venipuncture 65,743 38,247 $302K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 4,513 1,979 $282K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 7,416 2,496 $277K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,916 1,677 $273K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 10,894 6,240 $271K
62323 580 456 $266K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4,070 2,410 $254K
64635 130 80 $250K
71045 Radiologic examination, chest; single view 5,661 4,452 $244K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2,479 2,235 $243K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1,129 581 $239K
77067 Screening mammography, bilateral, including computer-aided detection 3,009 2,925 $228K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2,815 1,217 $198K
71275 Computed tomographic angiography, chest, with contrast material 1,437 1,301 $179K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,155 2,037 $176K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,714 2,397 $175K
71260 Computed tomography, thorax, diagnostic; with contrast material 1,230 898 $165K
96376 4,792 2,885 $163K
76830 Ultrasound, transvaginal 1,682 1,524 $153K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 5,111 4,574 $147K
64494 303 204 $144K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 353 203 $136K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 212 96 $129K
80053 Comprehensive metabolic panel 17,853 15,692 $114K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 26,228 22,222 $113K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3,634 3,046 $112K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 197 148 $102K
72100 2,113 1,851 $95K
11043 306 138 $94K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 547 499 $88K
73630 2,374 2,180 $85K
97530 Therapeutic activities, direct patient contact, each 15 minutes 2,268 1,050 $84K
94726 543 500 $83K
73564 1,919 1,649 $79K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1,619 1,553 $78K
80048 Basic metabolic panel (calcium, ionized) 18,482 15,255 $78K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 286 240 $76K
10060 378 334 $68K
71271 847 792 $67K
73130 1,884 1,681 $65K
84484 10,961 7,314 $62K
73610 2,117 1,906 $61K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,024 925 $60K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 11,344 9,714 $58K
84443 Thyroid stimulating hormone (TSH) 4,553 4,357 $57K
77063 Screening digital breast tomosynthesis, bilateral 2,432 2,096 $56K
97162 1,162 668 $51K
84702 7,363 6,728 $50K
73030 1,584 1,311 $48K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,291 1,146 $46K
72125 Computed tomography, cervical spine; without contrast material 937 879 $46K
80061 Lipid panel 4,189 3,108 $44K
12001 410 386 $42K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,815 1,766 $41K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 533 485 $40K
64636 64 50 $40K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,836 1,757 $40K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,820 1,756 $40K
96367 901 413 $40K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,885 1,377 $39K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 31 27 $39K
73110 1,184 1,023 $35K
29125 347 334 $35K
99281 Emergency department visit for the evaluation and management, self-limited or minor 307 301 $34K
85027 9,630 8,783 $34K
82962 8,788 3,641 $33K
83690 8,552 7,798 $30K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 8,624 7,255 $30K
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg 1,227 680 $29K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,855 1,468 $29K
71250 451 338 $29K
93971 339 322 $25K
77066 Tomosynthesis, mammo 323 265 $25K
93017 235 218 $25K
83880 1,375 1,302 $23K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,101 1,086 $22K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 984 930 $22K
82565 1,825 1,054 $22K
83036 Hemoglobin; glycosylated (A1C) 2,671 2,578 $22K
94729 374 366 $21K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 727 351 $20K
80076 3,902 3,632 $20K
90853 Group psychotherapy (other than of a multiple-family group) 926 126 $19K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,337 1,516 $19K
76642 340 300 $18K
87631 185 168 $18K
J2270 Injection, morphine sulfate, up to 10 mg 7,598 4,989 $17K
85610 6,996 4,250 $17K
81025 1,149 1,042 $17K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 3,947 3,391 $17K
99219 316 104 $17K
J2405 Injection, ondansetron hydrochloride, per 1 mg 16,051 12,981 $16K
82077 1,937 1,755 $16K
81001 8,079 7,456 $16K
A9575 Injection, gadoterate meglumine, 0.1 ml 632 511 $16K
70496 130 110 $16K
J2250 Injection, midazolam hydrochloride, per 1 mg 4,616 4,023 $15K
73502 481 400 $15K
90715 834 643 $14K
76770 193 172 $14K
87086 Culture, bacterial; quantitative colony count, urine 3,415 3,148 $14K
85379 2,613 2,509 $13K
70498 156 151 $13K
70551 Magnetic resonance imaging, brain; without contrast material 72 64 $13K
74018 306 280 $13K
83605 2,312 1,865 $13K
G0297 Low dose ct scan (ldct) for lung cancer screening 173 162 $13K
36591 218 135 $11K
82607 690 667 $10K
84703 2,517 2,365 $10K
76536 122 115 $10K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 13 12 $10K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 353 311 $10K
87522 Neg quan hep c or qual rna 273 257 $10K
J1885 Injection, ketorolac tromethamine, per 15 mg 6,829 5,813 $9K
77080 177 160 $9K
86900 682 635 $9K
73080 276 234 $9K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 1,737 1,163 $9K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 793 660 $9K
87430 1,499 1,454 $9K
J1200 Injection, diphenhydramine hcl, up to 50 mg 3,202 2,333 $9K
J3010 Injection, fentanyl citrate, 0.1 mg 6,854 4,702 $8K
83735 2,169 1,738 $8K
84145 566 521 $8K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 536 512 $8K
84439 975 936 $8K
71101 185 155 $8K
81003 4,423 4,180 $7K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 36 12 $7K
72050 127 116 $7K
87077 1,206 1,077 $7K
82803 527 477 $7K
88304 333 321 $6K
86140 1,540 1,410 $6K
J1650 Injection, enoxaparin sodium, 10 mg 3,005 624 $6K
12002 39 37 $6K
J1815 Injection, insulin, per 5 units 2,970 737 $6K
94761 434 199 $5K
70491 42 37 $5K
70486 72 69 $5K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 130 118 $5K
C9290 Injection, bupivacaine liposome, 1 mg 48 27 $5K
97161 146 66 $5K
87040 685 361 $4K
J0690 Injection, cefazolin sodium, 500 mg 2,071 1,638 $4K
J0780 Injection, prochlorperazine, up to 10 mg 408 303 $4K
87186 994 915 $4K
80074 199 186 $4K
J0330 Injection, succinylcholine chloride, up to 20 mg 1,037 963 $3K
82570 725 646 $3K
94060 17 15 $3K
76942 40 37 $3K
82728 310 297 $3K
A9577 Injection, gadobenate dimeglumine (multihance), per ml 249 214 $3K
85652 1,494 1,371 $3K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 1,414 790 $3K
82746 230 224 $3K
80143 340 321 $3K
73140 139 136 $3K
87070 563 385 $2K
93880 25 24 $2K
29515 13 13 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 118 105 $2K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 37 37 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 1,107 802 $2K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 1,124 1,062 $2K
36416 211 106 $2K
V2632 Posterior chamber intraocular lens 58 50 $2K
87210 944 906 $2K
93923 38 27 $2K
C9113 Injection, pantoprazole sodium, per vial 783 444 $2K
93970 12 12 $2K
87205 787 672 $2K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 26 12 $2K
95886 13 12 $2K
J2060 Injection, lorazepam, 2 mg 1,331 1,030 $2K
80069 244 163 $2K
85730 528 475 $2K
J2785 Injection, regadenoson, 0.1 mg 37 27 $2K
97010 206 102 $2K
J1170 Injection, hydromorphone, up to 4 mg 1,878 1,494 $2K
80179 243 232 $2K
88307 12 12 $2K
86850 233 217 $2K
73590 60 53 $1K
73090 28 27 $1K
83540 296 284 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 2,359 1,675 $1K
88738 152 91 $1K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 12 12 $1K
86901 675 637 $1K
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 129 123 $1K
J1790 Injection, droperidol, up to 5 mg 895 764 $1K
86780 128 117 $1K
93225 17 16 $1K
94010 13 12 $1K
83550 166 156 $998.63
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 579 511 $990.45
87340 110 104 $949.96
83970 24 24 $885.04
J2919 Injection, methylprednisolone sodium succinate, 5 mg 144 97 $880.03
77065 Tomosynthesis, mammo 15 12 $877.80
86481 12 12 $855.95
96415 14 12 $852.35
72072 15 12 $834.01
97116 62 28 $792.82
J2765 Injection, metoclopramide hcl, up to 10 mg 526 432 $785.54
93226 15 15 $745.47
82550 176 156 $671.51
J1980 Injection, hyoscyamine sulfate, up to 0.25 mg 53 49 $571.51
J1030 Injection, methylprednisolone acetate, 40 mg 147 126 $551.45
J2550 Injection, promethazine hcl, up to 50 mg 585 461 $519.84
P9612 Catheterization for collection of specimen, single patient, all places of service 48 16 $507.79
86803 41 39 $492.74
87808 46 45 $479.16
84100 138 109 $447.17
J0697 Injection, sterile cefuroxime sodium, per 750 mg 122 81 $441.48
G0008 Administration of influenza virus vaccine 13 13 $365.30
82805 47 41 $326.64
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 74 70 $297.70
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 92 86 $295.59
97535 Self-care/home management training, each 15 minutes 16 13 $275.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 61 55 $266.53
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 23 12 $225.23
82043 38 38 $183.79
A9270 Non-covered item or service 495 85 $175.52
90686 18 18 $169.32
87807 67 60 $158.08
82977 128 115 $153.22
J3475 Injection, magnesium sulfate, per 500 mg 69 61 $132.04
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 100 69 $130.72
87088 28 25 $122.25
J0171 Injection, adrenalin, epinephrine, 0.1 mg 64 42 $62.23
84550 13 12 $56.78
J1596 Injection, glycopyrrolate, 0.1 mg 136 130 $50.95
99152 14 14 $48.63
J3360 Injection, diazepam, up to 5 mg 15 12 $45.71
J1171 Injection, hydromorphone, 0.1 mg 25 21 $28.18
J2470 Injection, pantoprazole sodium, 40 mg 25 15 $25.33
J1836 Injection, metronidazole, 10 mg 31 13 $23.34
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 697 177 $17.52
J3370 Injection, vancomycin hcl, 500 mg 86 54 $15.69
J2370 Injection, phenylephrine hcl, up to 1 ml 40 29 $7.33
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 12 12 $0.46
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 72 67 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 68 42 $0.00
80305 13 12 $0.00
00142 107 76 $0.00
Q0164 Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 35 16 $0.00